Schroder Investment Management Group’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
FLAM
GF
NAMI
B
Schroder Investment Management Group's NEO Position: Q2 2026 in Review
Schroder Investment Management Group increased its NeoGenomics (NEO) stake by 22% in Q2 2026, buying an estimated $7.47M and bringing the position to 4,342,883 shares worth $61.9M. The position accounts for 0.04% of the portfolio, ranked #305.
Schroder Investment Management Group first reported a position in NEO in Q3 2021 and has held it in 20 quarters since. The position peaked at $63M in Q4 2021. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.
- Schroder Investment Management Group held 4,342,883 shares of NeoGenomics worth $61.9M as of Q2 2026.
- Schroder Investment Management Group bought 774,305 NeoGenomics shares in Q2 2026, an estimated $7.47M.
- NeoGenomics made up 0.04% of Schroder Investment Management Group's portfolio in Q2 2026, its #305 holding.
- Schroder Investment Management Group first reported a position in NeoGenomics in Q3 2021 and has held it in 20 quarters since.
- Schroder Investment Management Group's NeoGenomics position peaked at $63M in Q4 2021.
- 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.
Based on Schroder Investment Management Group's 13F filing for Q2 2026, filed 13 Aug 2026.